Skip to main content

and
  1. Article

    Open Access

    Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors

    BRAFV600E represents a constitutively active onco-kinase and stands as the most prevalent genetic alteration in thyroid cancer. However, the clinical efficacy of small-molecule inhibitors targeting BRAFV600E is o...

    Fang Sui, Guanjie Wang, Juan Liu, Mengmeng Yuan in Cellular and Molecular Life Sciences (2024)

  2. Article

    Open Access

    Characterization of gene regulatory networks underlying key properties in human hematopoietic stem cell ontogeny

    Human hematopoiesis starts at early yolk sac and undergoes site- and stage-specific changes over development. The intrinsic mechanism underlying property changes in hematopoiesis ontogeny remains poorly unders...

    Fei Li, Yanling Zhu, Tianyu Wang, Jun Tang, Yuhua Huang, Jiaming Gu in Cell Regeneration (2024)

  3. Article

    Open Access

    A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

    Idiopathic pulmonary fibrosis (IPF) is an aggressive interstitial lung disease with a high mortality rate. Putative drug targets in IPF have failed to translate into effective therapies at the clinical level. ...

    Feng Ren, Alex Aliper, Jian Chen, Heng Zhao, Sujata Rao in Nature Biotechnology (2024)

  4. No Access

    Protocol

    Measurement of VEGF Content in Exosomes and Subsequent Tumor Tubulogenesis and In Vivo Angiogenesis Functional Assays

    Vascular endothelial growth factor (VEGF) plays a vital role in angiogenesis, and is also involved in tumor cell growth and immunosuppression, showing very complex roles. VEGF-exosomes are released by tumor en...

    Ye Zeng, **aoqiang Du, Wenli Jiang, Yan Qiu in VEGF Signaling (2022)

  5. No Access

    Article

    LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4

    Oxidative low-density lipoprotein (ox-LDL)-induced endothelial cell injury is a key contributor to atherosclerosis development. However, the role and mechanism of long noncoding RNA X-inactive specific transcr...

    Guoyong Lu, Peng Tian, Yongxin Zhu, **aohua Zuo, **aoqiang Li in Journal of Biosciences (2020)

  6. No Access

    Article

    miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway

    Hypertrophic scar (HS) is a serious skin fibrotic disease characterized by the excessive proliferation of fibroblasts and often considered as a kind of benign skin tumor. microRNA-155 (miR-155) is usually serv...

    Xue Wu, Jun Li, Xuekang Yang, **aozhi Bai, Jihong Shi in Journal of Molecular Histology (2018)

  7. No Access

    Article

    MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1

    Hypertrophic scar (HS) is a fibro-proliferative disorder which is characterized by excessive deposition of collagen and accumulative activity of myofibroblasts. Increasing evidences have demonstrated miRNAs pl...

    Yan Li, Julei Zhang, Wei Zhang, Yang Liu, Yuehua Li in Journal of Molecular Histology (2017)